CIK 0000875045
- Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330112644
- Phone
- +1 617-679-2000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-13 | Murphy Nicole Head of Pharm Ops and Tech | Grant or award · Restricted Stock Unit | +10,560 | 10,560 | ||
| 2026-02-12 | Murphy Nicole Head of Pharm Ops and Tech | Purchase | +3 | $195.04 | $585 | 19,611.04 |
| 2026-02-06 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise | +2,102 | 16,324.04 | ||
| 2026-02-06 | Murphy Nicole Head of Pharm Ops and Tech | Shares withheld for taxes | −1,017 | $201.18 | $205K | 15,307.04 |
| 2026-02-06 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise | +1,940 | 17,247.04 | ||
| 2026-02-06 | Murphy Nicole Head of Pharm Ops and Tech | Shares withheld for taxes | −914 | $201.18 | $184K | 16,333.04 |
| 2026-02-06 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise | +4,683 | 21,016.04 | ||
| 2026-02-06 | Murphy Nicole Head of Pharm Ops and Tech | Shares withheld for taxes | −1,408 | $201.18 | $283K | 19,608.04 |
| 2026-02-06 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise · Restricted Stock Unit | −2,102 | 0 | ||
| 2026-02-06 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise · Restricted Stock Unit | −1,940 | 1,940 | ||
| 2026-02-06 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise · Restricted Stock Unit | −4,683 | 9,367 | ||
| 2025-02-10 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise | +2,272 | 14,725.37 | ||
| 2025-02-10 | Murphy Nicole Head of Pharm Ops and Tech | Shares withheld for taxes | −670 | $142.54 | $96K | 14,055.37 |
| 2025-02-10 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise · Restricted Stock Unit | −2,272 | 0 | ||
| 2025-02-07 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise | +2,102 | 11,736.37 | ||
| 2025-02-07 | Murphy Nicole Head of Pharm Ops and Tech | Shares withheld for taxes | −620 | $141.35 | $88K | 11,116.37 |
| 2025-02-07 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise | +1,940 | 13,056.37 | ||
| 2025-02-07 | Murphy Nicole Head of Pharm Ops and Tech | Shares withheld for taxes | −603 | $141.35 | $85K | 12,453.37 |
| 2025-02-07 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise · Restricted Stock Unit | −2,102 | 2,102 | ||
| 2025-02-07 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise · Restricted Stock Unit | −1,940 | 3,880 |
Page 1 of 4 · 78 trades